5-Ethyl-2-(5-{[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl}-2-propoxyphenyl)-7-propyl-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one(CAS: 862189-95-5)

This compound falls under multiple regulatory frameworks including GHS for hazardous classification, REACH for European manufacturers and importers, and FDA/EPA for pharmaceutical and environmental concerns. Specific handling and storage guidelines must be followed based on its identified hazards and intended use.

Synthesis alternatives include using isomers or analogs of the compound, or exploring alternative reagents such as other pyrimidinones and piperazinyl derivatives. These alternatives can provide similar functionalities but with different chemical structures.

The market trend for this compound is driven by its use in pharmaceutical research, particularly in the development of anti-inflammatory and antiviral drugs. Research is focusing on optimizing its therapeutic index and exploring new applications in biotechnology and drug delivery systems.

Waste containing this compound should be collected and stored in sealed containers. For safe disposal, it is recommended to consult with a hazardous waste management company for incineration or other professional disposal methods. Environmental precautions include ensuring no spillage and proper labeling of waste containers.